Optimizing Antimicrobial Peptide Dendrimers in Chemical Space

Area of Science:

• Medicinal Chemistry
• Biotechnology
• Computational Chemistry

Background:

• Antimicrobial peptide dendrimers (AMPDS) are promising therapeutics but require optimization for broader efficacy and stability.
• Existing AMPDS face challenges with activity spectrum and stability in biological environments.
• Dendrimer size has been a theoretical limitation for their antimicrobial applications.

Purpose of the Study:

• To enhance the activity and stability of antimicrobial peptide dendrimers (AMPDS) using computational methods.
• To identify novel dendrimer structures with improved efficacy against challenging Gram-negative pathogens.
• To investigate the mechanism of action and in vivo potential of optimized AMPDS.

Main Methods:

• Nearest-neighbor searches in chemical space for structure-activity relationship analysis.
• Identification and characterization of a novel dendrimer, T7.
• In vitro antimicrobial assays against Gram-negative bacteria, including Klebsiellae pneumoniae.
• In vivo infection models using multidrug-resistant Acinetobacter baumannii.
• Imaging, spectroscopic studies, and molecular dynamics simulations to elucidate the mechanism of action.

Main Results:

• Dendrimer T7 demonstrated an expanded activity range against Gram-negative pathogenic bacteria, including Klebsiellae pneumoniae.
• T7 exhibited increased serum stability compared to parent compounds.
• Promising in vivo activity was observed against a multidrug-resistant strain of Acinetobacter baumannii.
• Mechanism of action involves membrane disruption, supported by imaging, spectroscopy, and molecular dynamics simulations.
• This study represents the first virtual screening application in dendrimer research.

Conclusions:

• Virtual screening is effective for optimizing antimicrobial peptide dendrimers (AMPDS).
• Dendrimer T7 is a potent AMPD with broad-spectrum activity, enhanced stability, and in vivo efficacy.
• Dendrimer size is not a limiting factor for the activity of AMPDS.
• These findings open new avenues for developing dendrimer-based antimicrobials against resistant bacteria.